Intrapulmonary percussive ventilation (IPV) in acute exacerbations of chronic obstructive pulmonary disease (COPD) patients with mild respiratory acidosis: a randomised controlled trial
| ISRCTN | ISRCTN17802078 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN17802078 |
| Protocol serial number | N/A |
| Sponsor | Pellegrin-Tripode Hospital (France) |
| Funder | Not provided at time of registration |
- Submission date
- 15/04/2005
- Registration date
- 18/04/2005
- Last edited
- 13/06/2014
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Frederic Vargas
Scientific
Scientific
Pellegrin-Tripode Hospital
Bordeaux
33076
France
| frederic.vargas@chu-bordeaux.fr |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | |
| Study objectives | We hypothesised that the use of intrapulmonary percussive ventilation (IPV), a technique designed to improve mucus clearance, could prove effective in avoiding further deterioration in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) with mild respiratory acidosis. |
| Ethics approval(s) | The experimental protocol was approved by the institutional review board of the hospital |
| Health condition(s) or problem(s) studied | Acute exacerbations of chronic obstructive pulmonary disease (COPD) patients with mild respiratory acidosis |
| Intervention | Comparison of two groups of COPD: 1. A standard goup: COPD patients with standard treatment alone 2. An IPV group: COPD patients with standard treatment plus IPV |
| Intervention type | Other |
| Primary outcome measure(s) |
Therapy was considered to be successful when it enabled the avoidance of both a worsening of the exacerbation and a decrease in pH to under 7.35 (which would have required NIV), and allowed the patient to be discharged from the ICU. |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 31/12/2004 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Target sample size at registration | 33 |
| Key inclusion criteria | COPD patients in acute excerbations and respiratory acidosis with pH between 7.35 and 7.38 |
| Key exclusion criteria | 1. The requirement for emergency intubation for cardiopulmonary resuscitation, respiratory arrest, or in the case of rapid deterioration in neurological status (Glasgow coma scale inferior or equal to 8) 2. Hemodynamic instability defined as a systolic blood pressure of less than 80 mmHg or evidence on electrocardiography of ischemia or clinically significant ventricular arrhythmias 3. Failure of more than two additional organs; or tracheotomy, pneumothorax, facial deformity, or a recent history of oral, oesophageal or gastric surgery |
| Date of first enrolment | 01/01/2003 |
| Date of final enrolment | 31/12/2004 |
Locations
Countries of recruitment
- France
Study participating centre
Pellegrin-Tripode Hospital
Bordeaux
33076
France
33076
France
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/08/2005 | Yes | No | |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |